Back during webinar at the end of Feb WP said it would take 6 months to get things ticking over. August is month 6 and we are finally hearing that sales are breaking out and that we have had our best month YTD. Based on these comments logic would suggest this is $800k - $1M.
Because a large number off us are so in the red it seems that any positive news will never be enough unless it is a silver bullet that will turn the share price around in a day. Somewhat fair given the patience that has already been shown.
The change of financial year will be a real positive for the share price IMO. It gives AHZ an additional 6 months to lock in growth and hopefully profitability. This will mean the guidance given to the market for the new F18 will be a lot stronger than if the current 6 months were included.
Let's just hope significant traction is gained over the next 6 months with ADAPT and clarity has been provided around the immunotherapies division.
$3M minimum for ADAPT this quarter for me, if that's not achieved, I will start to jump on the nervous investor bandwagon.
GLTAH
Admedus dominating in Europe., page-52
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.68 |
Change
0.680(4.53%) |
Mkt cap ! $331.4M | |||
| Open | High | Low | Value | Volume |
| $14.90 | $15.75 | $14.85 | $431.9K | 28.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200 | $15.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.95 | 300 | 1 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |